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In 2013, The American College of
Obstetricians and Gynecologists ( ACOG)
made a recommendation to withhold
Ibuprofen in postpartum Preeclamptic
women.
The U.S. is currently confronted with a
growing narcotic dependence and the ability
to use alternative analgesic methods is
imperative in reducing narcotic use .
Chang A Et al (2017) reported better pain
reduction with a combination of ibuprofen and
acetaminophen than with narcotics.
The benefit of Ibuprofen in the postpartum
period is paramount in managing pain,
decreasing swelling and helping reduce
muscle aches and uterine cramping. When
combined with acetaminophen, it is a viable
non opioid alternative for acute pain control.

Current literature reports that Ibuprofen is
safe in most postpartum Preeclamptic
patients (exceptions include patients with
elevated serum AST, ALT >200mg/dL &
serum creatinine >1.0mg/dL).

Purpose

To study the impact of Ibuprofen on blood
pressure in the immediate postpartum period
in women with Preeclampsia on the Perinatal
Special Care Unit (PSCU) at Providence St.
Vincent Medical Center.
PICOT Question:
In postpartum women with Preeclampsia,
does administering Ibuprofen, compared to
not administering Ibuprofen, increase blood
pressure within 24-96 hours of delivery?

Discussion/Conclusions

Results

Background

Methods
IRB approved study of patients delivered
between 12/30/2016 and 12/31/2017. Total
sample of 633 patients who had severe
blood pressure (BP ≥ 160/105) during their
hospital stay.
Inclusion criteria: Preeclampsia
diagnosis, postpartum magnesium infusion,
with treated severe range blood pressures
in postpartum (BP ≥ 160/105). N=169. 66
received ibuprofen, 103 did not.

A retrospective chart audit was completed
on 44 randomly selected Preeclamptic
postpartum patients. Data collected
included 22 patients who received
ibuprofen and 22 patients who did not.

Results were obtained by comparing a
MAP point difference from the baseline.
When patient’s who DID receive
Ibuprofen were compared with patient’s
who did NOT receive Ibuprofen, the
results indicated no significant changes
from baseline. (See Figure 1.)
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Figure 1. Baseline Blood Pressure Changes

When comparing the average overall
MAP pressures between the two
groups of patients, there was no
significant increase in blood
pressures at the following time
intervals: 24, 48, 72 and > 96 hours.
(See Figure 2.)

Key limitations of this retrospective
chart audit include the limited number of
patients obtained for the project. There
were many patients available to audit,
but the data extraction process was
extremely time consuming.
The implications of practice with the
ability to use Ibuprofen following the birth
will reduce narcotic dependence, provide
excellent pain control specific to the
postpartum period, and be safe to use in
regards to not elevating blood pressures
in women with Preeclampsia.
Next steps: PSCU will be implementing
the new practice of administering
Ibuprofen to postpartum patients with
Preeclampsia who meet criteria.
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